1. Home
  2. TLN vs GH Comparison

TLN vs GH Comparison

Compare TLN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLN

Talen Energy Corporation

HOLD

Current Price

$325.61

Market Cap

14.2B

Sector

Utilities

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$87.65

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLN
GH
Founded
2015
2011
Country
United States
United States
Employees
1880
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
13.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TLN
GH
Price
$325.61
$87.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
20
Target Price
$433.50
$117.80
AVG Volume (30 Days)
733.3K
1.5M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$58.42
$33.40
Revenue Next Year
$16.37
$28.32
P/E Ratio
$83.51
N/A
Revenue Growth
N/A
32.88
52 Week Low
$162.31
$36.36
52 Week High
$451.28
$120.74

Technical Indicators

Market Signals
Indicator
TLN
GH
Relative Strength Index (RSI) 45.44 43.13
Support Level $307.79 $82.26
Resistance Level $397.04 $90.28
Average True Range (ATR) 14.64 3.61
MACD 0.71 0.45
Stochastic Oscillator 51.56 59.11

Price Performance

Historical Comparison
TLN
GH

About TLN Talen Energy Corporation

Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: